pharmacopeia
GET
/api/v1/drug/magnesium

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Acid-Base Activity; Electrolyte Activity; Enzyme Interactions.

Indications

Sourced from openFDA
  • Uses: • For relief of occasional constipation (irregularity).ICD-10: K59.00

Dosage & administration

Sourced from openFDA

Directions: • shake well before using • drink a full glass (8 ounces) of liquid with each dose • may be taken as a single daily dose or in divided doses adults and children 12 years of age and over 6.5 to 10 fl oz maximum 10 fl oz in 24 hours children 6 to under 12 years of age 3 to 7 fl oz maximum 7 fl oz in 24 hours children 2 to under 6 years of age 2 to 3 fl oz maximum 3 fl oz in 24 hours children under 2 years of age ask a doctor

Warnings & precautions

Sourced from openFDA

Ask a doctor before use if you have • Kidney disease • a magnesium restricted diet • Abdominal pain, nausea, or vomiting • Noticed a sudden change in bowel habits that persists over a period of 2 weeks • Already used a laxative for a period longer than 1 week Ask a doctor or pharmacist before use if you are • Taking any other drug. • Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work. Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use. These could be signs of a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Approval history

Sourced from openFDA
  • Aug 13, 1975NDANDA017586Otsuka Icu Medcl
  • Aug 13, 1975NDANDA017609Otsuka Icu Medcl
  • Aug 13, 1975NDANDA017610Otsuka Icu Medcl
  • Sep 27, 1978NDANDA017512Vantive Us Hlthcare
  • Feb 2, 1979NDANDA017378Baxter Hlthcare
  • Feb 2, 1979NDANDA017484Baxter Hlthcare
  • Feb 19, 1982NDANDA018508Baxter Hlthcare
  • Feb 26, 1982NDANDA018608Hospira

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
813,621 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Nausea51,5386.3%
  2. 2Fatigue45,9825.7%
  3. 3Diarrhoea45,4665.6%
  4. 4Drug Ineffective43,7725.4%
  5. 5Chronic Kidney Disease42,7365.3%
  6. 6Dyspnoea37,5574.6%
  7. 7Pain36,2824.5%
  8. 8Headache36,0784.4%
  9. 9Vomiting34,6344.3%
  10. 10Off Label Use32,2094.0%
  11. 11Dizziness30,7683.8%
  12. 12Acute Kidney Injury30,5793.8%
  13. 13Malaise28,5643.5%
  14. 14Death28,3163.5%
  15. 15Asthenia26,3803.2%

Literature

View JSON

Recent PubMed references pinned to Magnesium as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 2,049 ClinicalTrials.gov registrations naming Magnesium as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Magnesium work?
Mechanism-of-action classes: Acid-Base Activity; Electrolyte Activity; Enzyme Interactions.
What is Magnesium used for?
According to FDA labeling, Magnesium carries indications including: Uses: • For relief of occasional constipation (irregularity).. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Magnesium?
Magnesium is classified as Acid-Base Activity, Electrolyte Activity, Enzyme Interactions, Cellular Activity Alteration.
Note. Data for magnesium is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients